SCHEMBL7020718

SCHEMBL7020718

O=C(CCC1CC1)c1ccc(Br)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.52
HDAC1 Q13547 5/20 0.49
HDAC3 O15379 3/20 0.49
HDAC2 Q92769 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HDAC8 Q9BY41 3/20 0.49
HDAC4 P56524 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
CYP2J2 P51589 1/20 0.48
BCHE P06276 2/20 0.48
ACHE P22303 2/20 0.48
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453020 0.81 NPC1 (0.60) BCHEACHEKMT2AKCNH2
SCHEMBL13814798 0.81 BCHE (0.67) HDAC1HDAC3HDAC2SMN1; SMN2HDAC8
SCHEMBL10555303 0.80 CYP2C9 (0.50) GSK3BHDAC1HDAC3HDAC2HDAC8
SCHEMBL19707265 0.80 KMT2A (0.50) SMN1; SMN2BCHEACHEALDH1A1MAPT
SCHEMBL241664 0.80 GSK3B (0.70) GSK3BHDAC1HDAC3HDAC2SMN1; SMN2
SCHEMBL25244154 0.79 ACHE (0.83) BCHEACHEALDH1A1MAPT
SCHEMBL3392114 0.79 KMT2A (0.51) GSK3BHDAC1HDAC3HDAC2SMN1; SMN2
SCHEMBL18605000 0.78 NPC1 (0.41) HDAC1HDAC3HDAC2SMN1; SMN2BCHE
SCHEMBL29826066 0.78 NPC1 (0.41) HDAC1HDAC3HDAC2SMN1; SMN2BCHE
SCHEMBL17065065 0.78 MAPT (0.51) BCHEACHEALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280809-A1 ANTITUMORAL ECTEINASCIDIN DERIVATIVES PHARMA MAR, S.A. (ES) 2003-02-05 EP disclosed
WO-2001077115-A1 ANTITUMORAL ECTEINASCIDIN DERIVATIVES PHARMA MAR, S.A. (ES) 2001-10-18 WO disclosed